Human Microbiome Market Size, Competitors & Forecast to 2030

The Human Microbiome Market grew from USD 1.58 billion in 2023 to USD 1.96 billion in 2024. It is expected to continue growing at a CAGR of 23.90%, reaching USD 7.11 billion by 2030.

These include bacteria, archaea, viruses, and eukaryotic microbes. The human body hosts trillions of these microbial cells, which can influence bodily functions and health. It assists in the digestion of food, protection against pathogens, and the development of the immune system. Meanwhile, the rise in chronic disease prevalence and a growing need for research linking the microbiome to various health conditions further stokes demand for microbiome-based diagnostics and therapeutics. The growing need for a microbiome in nutrition propels the demand for a human microbiome to support and influence overall wellness and immune function. However, the regulatory hurdles associated with approving live biotherapeutic products and complexities in comprehending and manipulating the microbiome present a significant challenge for the key players. Companies are continuously focusing on research and development (R&D) activities and cost-effective and accessible sequencing technologies to optimize their business growth. Moreover, the advancements in developing novel human microbiome therapeutics and rising investments present a significant opportunity for the key companies operating in the global space. Emerging technologies such as artificial intelligence (AI) and advanced machine learning (ML) are integrated with microbiome research to understand complex microbial interactions better and develop novel therapeutic solutions.

Regional Insights

In the Americas, the United States and Canada witnessed significant growth in human microbiome driven by the research and commercialization of advanced microbiome, with numerous companies actively engaged in developing microbiome-based therapies and diagnostics. The human microbiome landscape in this region is steadily growing, focusing on research aimed at understanding the impact of the microbiome on human health and disease. On the other hand, European countries exhibit strong government support for microbiome research with numerous initiatives and research consortia in place. The regulatory framework in Europe is evolving to support the safe and ethical use of microbiome data and products. The Middle East and Africa region represents a growing market for human microbiome products, primarily driven by an increasing burden of lifestyle diseases and growing healthcare expenditure. At the same time, the human microbiome landscape in the Asia-Pacific region is experiencing significant growth, driven by increasing awareness of the importance of microbial balance to overall health, rising healthcare expenditures, and advancements in microbial genomics. Research and development in probiotics, prebiotics, and symbiotics are growing in this region, particularly in addressing regional health issues such as gastrointestinal disorders and chronic diseases.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Human Microbiome Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Increased Focus on Development of Human Microbiome Therapy
Human Microbiome for Drug Discovery, Early Disease Detection, and Diagnosis
Increasing Demand for Microbiome in Probiotics and Infant Nutrition

Market Restraints

Limited Expertise and Safety Issue related to Microbiome Therapeutics

Market Opportunities

Increasing Collaborations and Research Investments to Create Growth Opportunities
Development of Novel Human Microbiome Therapeutic Products

Market Challenges

Limitations in Understanding Number of Bacterial Species and Uncertainty of Human Microbiome-Based Drugs

Market Segmentation Analysis

Technology: Recent advancements in 16s rRNA sequencing and omics technology to investigate molecular factors and processes in human body
Application: The increasing adoption of the human microbiome in healthcare diagnostics and therapeutics to cater to various health conditions

Industry Insights

Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Human Microbiome Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Human Microbiome Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Clinical Microbiomics Announces Merger with CosmosID

Clinical Microbiomics A/S, microbiome bioinformatics, and systems biology company merged with CosmosID Inc., an American CRO specializing in microbiome analysis compliant with CLIA and GxP standards. The merger creates an unprecedented microbiome service provider poised with a worldwide network of cutting-edge multi-omics laboratories, fortified by robust bioinformatics, the application of artificial intelligence, and the expertise in integrative systems biology adhering to GxP guidelines.

Nestlé Partners APC Microbiome on Health and Wellbeing Products

Nestlé embarked on a groundbreaking partnership with APC Microbiome Ireland, a research institution funded by Science Foundation Ireland, to delve deeper into the intricacies of the human microbiome. This partnership is poised to revolutionize Nestlé's health and wellness product range by incorporating advanced microbiome science into new product development. By leveraging APC Microbiome Ireland's cutting-edge research capabilities, Nestlé plans to leverage the complex interplay between nutrition and gut health, enhancing their offerings and fostering better health outcomes for consumers.

UW Medicine Launches a New Center to Study Microbiomes

UW Medicine inaugurated the Microbial Interactions & Microbiome Center, which stands at the forefront of investigating the complex ecosystems of microorganisms residing in varied habitats, including human niches such as the gastrointestinal tract, oral cavity, and skin. Central to the center's mission is to expand the understanding of the intricate relationships within these microbial communities comprised of bacteria, fungi, and myriad other minuscule organisms.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Human Microbiome Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Human Microbiome Market, highlighting leading vendors and their innovative profiles. These include AOBiome, LLC, Astarte Medical Partners, Inc, Axial Therapeutics, Inc., Azitra, BiomeSense, Inc., BiomX Ltd., DuPont de Nemours, Inc., Enterome Bioscience, Evelo Biosciences, Inc., Exeliom Biosciences SAS, Ferring B.V., Finch Therapeutics Group, Inc., Illumina, Inc., Intralytix, Inc., Invivo Healthcare, Locus Biosciences, Inc., Merck KGaA, Metabiomics Corporation, Osel Inc., Rebiotix Inc., Second Genome, Inc., Seres Therapeutics, Inc., Synlogic, Inc., Theriva Biologics, Inc., Vedanta Biosciences, Inc., Viome Life Sciences, Inc., and Yakult Honsha Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Human Microbiome Market to forecast the revenues and analyze trends in each of the following sub-markets:

Disease

Acute Diarrhea
Autoimmune Disorders
Cancer
Diabetes
Mental Disorders
Obesity

Technology

16s rRNA Sequencing
Cell Culture Technology
Computational Tools
High-Throughput Technology
Metagenomic Sequencing
Omics Technology

Product

Diagnostic Devices
Drugs
Foods
Prebiotic & Probiotics

Therapeutic Area

Gastrointestinal Disorders
Metabolic Disorders
Skin Disorders
Women’s Health

Application

Diagnostics
Therapeutics

Region

Americas

Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas

Asia-Pacific

Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa

Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased Focus on Development of Human Microbiome Therapy
5.1.1.2. Human Microbiome for Drug Discovery, Early Disease Detection, and Diagnosis
5.1.1.3. Increasing Demand for Microbiome in Probiotics and Infant Nutrition
5.1.2. Restraints
5.1.2.1. Limited Expertise and Safety Issue related to Microbiome Therapeutics
5.1.3. Opportunities
5.1.3.1. Increasing Collaborations and Research Investments to Create Growth Opportunities
5.1.3.2. Development of Novel Human Microbiome Therapeutic Products
5.1.4. Challenges
5.1.4.1. Limitations in Understanding Number of Bacterial Species and Uncertainty of Human Microbiome-Based Drugs
5.2. Market Segmentation Analysis
5.2.1. Technology: Recent advancements in 16s rRNA sequencing and omics technology to investigate molecular factors and processes in human body
5.2.2. Application: The increasing adoption of the human microbiome in healthcare diagnostics and therapeutics to cater to various health conditions
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
5.9.1. Intellectual Property Landscape

6. Human Microbiome Market, by Disease

6.1. Introduction
6.2. Acute Diarrhea
6.3. Autoimmune Disorders
6.4. Cancer
6.5. Diabetes
6.6. Mental Disorders
6.7. Obesity

7. Human Microbiome Market, by Technology

7.1. Introduction
7.2. 16s rRNA Sequencing
7.3. Cell Culture Technology
7.4. Computational Tools
7.5. High-Throughput Technology
7.6. Metagenomic Sequencing
7.7. Omics Technology

8. Human Microbiome Market, by Product

8.1. Introduction
8.2. Diagnostic Devices
8.3. Drugs
8.4. Foods
8.5. Prebiotic & Probiotics

9. Human Microbiome Market, by Therapeutic Area

9.1. Introduction
9.2. Gastrointestinal Disorders
9.3. Metabolic Disorders
9.4. Skin Disorders
9.5. Women’s Health

10. Human Microbiome Market, by Application

10.1. Introduction
10.2. Diagnostics
10.3. Therapeutics

11. Americas Human Microbiome Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Human Microbiome Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Human Microbiome Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Clinical Microbiomics Announces Merger with CosmosID
14.3.2. Nestlé Partners APC Microbiome on Health and Wellbeing Products
14.3.3. UW Medicine Launches a New Center to Study Microbiomes

15. Competitive Portfolio

15.1. Key Company Profiles
15.2. Key Product Portfolio

List of Figures

FIGURE 1. HUMAN MICROBIOME MARKET RESEARCH PROCESS
FIGURE 2. HUMAN MICROBIOME MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HUMAN MICROBIOME MARKET DYNAMICS
FIGURE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. HUMAN MICROBIOME MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. HUMAN MICROBIOME MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. HUMAN MICROBIOME MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 72. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 79. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 80. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 87. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 88. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 89. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 90. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 91. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 92. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 93. CANADA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 94. CANADA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 95. CANADA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 96. CANADA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 97. CANADA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 98. CANADA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 99. CANADA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 100. CANADA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 101. CANADA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. CANADA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. MEXICO HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 104. MEXICO HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 105. MEXICO HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 106. MEXICO HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 107. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. MEXICO HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 110. MEXICO HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 111. MEXICO HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. MEXICO HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 114. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 115. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 116. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 117. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 118. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 119. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 120. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 121. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 122. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 123. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 124. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 126. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 128. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 130. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 132. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 134. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 136. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 137. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 138. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 139. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 140. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 141. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 142. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 143. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 144. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 145. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 146. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 147. CHINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 148. CHINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 149. CHINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 150. CHINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 151. CHINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 152. CHINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 153. CHINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 154. CHINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 155. CHINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. CHINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. INDIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 158. INDIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 159. INDIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 160. INDIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 161. INDIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 162. INDIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 163. INDIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 164. INDIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 165. INDIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 166. INDIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 167. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 168. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 169. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 170. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 171. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 172. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 173. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 174. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 175. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. JAPAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 178. JAPAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 179. JAPAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 180. JAPAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 181. JAPAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. JAPAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. JAPAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 184. JAPAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 185. JAPAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. JAPAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 188. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 189. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 190. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 191. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 192. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 193. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 194. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 195. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 198. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 199. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 200. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 201. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 202. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 203. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 204. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 205. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 206. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 207. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 208. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 209. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 210. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 211. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 214. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 215. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 218. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 219. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 220. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 221. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 222. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 223. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 224. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 225. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 226. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 227. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 228. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 229. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 230. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 231. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 232. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 233. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 234. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 235. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. THAILAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 238. THAILAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 239. THAILAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 240. THAILAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 241. THAILAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 242. THAILAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 243. THAILAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 244. THAILAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 245. THAILAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. THAILAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 248. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 249. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 250. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 251. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 252. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 253. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 254. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 255. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 256. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 269. DENMARK HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 270. DENMARK HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 271. DENMARK HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 272. DENMARK HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 273. DENMARK HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 274. DENMARK HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 275. DENMARK HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 276. DENMARK HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 277. DENMARK HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. DENMARK HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. EGYPT HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 280. EGYPT HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 281. EGYPT HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 282. EGYPT HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 283. EGYPT HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 284. EGYPT HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 285. EGYPT HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 286. EGYPT HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 287. EGYPT HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 288. EGYPT HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 289. FINLAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 290. FINLAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 291. FINLAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 292. FINLAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 293. FINLAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 294. FINLAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 295. FINLAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 296. FINLAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 297. FINLAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 298. FINLAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 299. FRANCE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 300. FRANCE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 301. FRANCE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 302. FRANCE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 303. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 304. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 305. FRANCE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 306. FRANCE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 307. FRANCE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 308. FRANCE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 309. GERMANY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 310. GERMANY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 311. GERMANY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 312. GERMANY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 313. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 314. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 315. GERMANY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 316. GERMANY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 317. GERMANY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 318. GERMANY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 319. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 320. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 321. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 322. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 323. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 324. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 325. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 326. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 327. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 328. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 329. ITALY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 330. ITALY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 331. ITALY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 332. ITALY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 333. ITALY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 334. ITALY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 335. ITALY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 336. ITALY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 337. ITALY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 338. ITALY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 339. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 340. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 341. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 342. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 343. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 344. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 345. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 346. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 347. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 348. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 349. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 350. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 351. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 352. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 353. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 354. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 355. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 356. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 357. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 358. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 359. NORWAY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 360. NORWAY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 361. NORWAY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 362. NORWAY HUMAN MICROBIOME MARKET SIZE, BY TEC

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

AOBiome, LLC
Astarte Medical Partners, Inc
Axial Therapeutics, Inc.
Azitra
BiomeSense, Inc.
BiomX Ltd.
DuPont de Nemours, Inc.
Enterome Bioscience
Evelo Biosciences, Inc.
Exeliom Biosciences SAS
Ferring B.V.
Finch Therapeutics Group, Inc.
Illumina, Inc.
Intralytix, Inc.
Invivo Healthcare
Locus Biosciences, Inc.
Merck KGaA
Metabiomics Corporation
Osel Inc.
Rebiotix Inc.
Second Genome, Inc.
Seres Therapeutics, Inc.
Synlogic, Inc.
Theriva Biologics, Inc.
Vedanta Biosciences, Inc.
Viome Life Sciences, Inc.
Yakult Honsha Co., Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	180
Published	June 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.96 Billion
Forecasted Market Value ( USD ) by 2030	$ 7.11 Billion
Compound Annual Growth Rate	23.9%
Regions Covered	Global

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3697EUR$3,939USD£3,105GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€4645EUR$4,949USD£3,902GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6541EUR$6,969USD£5,494GBP

Global Human Microbiome Market by Disease (Acute Diarrhea, Autoimmune Disorders, Cancer), Technology (16s rRNA Sequencing, Cell Culture Technology, Computational Tools), Product, Therapeutic Area, Application - Forecast 2024-2030

Regional Insights

Market Insights

Market Dynamics

Market Drivers

Market Restraints

Market Opportunities

Market Challenges

Market Segmentation Analysis

Industry Insights

FPNV Positioning Matrix

Market Share Analysis

Recent Developments

Clinical Microbiomics Announces Merger with CosmosID

Nestlé Partners APC Microbiome on Health and Wellbeing Products

UW Medicine Launches a New Center to Study Microbiomes

Strategy Analysis & Recommendation

Key Company Profiles

Market Segmentation & Coverage

Disease

Technology

Product

Therapeutic Area

Application

Region

Americas

Asia-Pacific

Europe, Middle East & Africa

Table of Contents

Companies Mentioned (Partial List)

Methodology

Table Information

Regional Insights

Market Insights

Market Dynamics

Market Drivers

Market Restraints

Market Opportunities

Market Challenges

Market Segmentation Analysis

Industry Insights

FPNV Positioning Matrix

Market Share Analysis

Recent Developments

Clinical Microbiomics Announces Merger with CosmosID

Nestlé Partners APC Microbiome on Health and Wellbeing Products

UW Medicine Launches a New Center to Study Microbiomes

Strategy Analysis & Recommendation

Key Company Profiles

Market Segmentation & Coverage

Disease

Technology

Product

Therapeutic Area

Application

Region

Americas

Asia-Pacific

Europe, Middle East & Africa

Table of Contents

Companies Mentioned (Partial List)

Methodology

Table Information

Related Topics

Related Reports

Global Microbiome Therapeutics Market by Type (Fecal Microbiota Transplantation, Microbiome Drugs, Probiotics & Prebiotics), Application (Autoimmune Diseases, Gastrointestinal Disorders, Infectious Diseases), End-use - Forecast 2024-2030

Human Microbiome Market: Trends, Forecast and Competitive Analysis [2024-2030]

Human Microbiome - Global Strategic Business Report

Global Human Microbiome Modulators Market Outlook Report: Industry Size, Competition, Trends and Growth Opportunities by Region, YoY Forecasts from 2024 to 2031

Global Microbiome Diagnostics Market by Product Type (Instruments, Reagents & Kits), Application (Gastrointestinal Disorders, Infectious Diseases, Metabolic Disorders), End-user - Forecast 2024-2030

About the Human Microbiome Market